LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | SNS-032 | 3.33 | uM | LJP6 | 2 | H14 | 72 | hr | 658 | 501 | 3807 | 0.1316 | -0.1022 |
Hs 578T | SNS-032 | 3.33 | uM | LJP6 | 3 | H14 | 72 | hr | 658 | 564 | 3769 | 0.1496 | -0.0595 |
Hs 578T | SNS-032 | 10 | uM | LJP6 | 1 | H13 | 72 | hr | 658 | 526 | 3705 | 0.1419 | -0.0860 |
Hs 578T | SNS-032 | 10 | uM | LJP6 | 2 | H13 | 72 | hr | 658 | 506 | 3807 | 0.1329 | -0.0986 |
Hs 578T | SNS-032 | 10 | uM | LJP6 | 3 | H13 | 72 | hr | 658 | 526 | 3769 | 0.1395 | -0.0852 |
Hs 578T | Afatinib | 0.04 | uM | LJP6 | 1 | G24 | 72 | hr | 658 | 3551 | 3705 | 0.9582 | 0.9661 |
Hs 578T | Afatinib | 0.04 | uM | LJP6 | 2 | G24 | 72 | hr | 658 | 3643 | 3807 | 0.9568 | 0.9654 |
Hs 578T | Afatinib | 0.04 | uM | LJP6 | 3 | G24 | 72 | hr | 658 | 3476 | 3769 | 0.9221 | 0.9366 |
Hs 578T | Afatinib | 0.12 | uM | LJP6 | 1 | G23 | 72 | hr | 658 | 3640 | 3705 | 0.9822 | 0.9857 |
Hs 578T | Afatinib | 0.12 | uM | LJP6 | 2 | G23 | 72 | hr | 658 | 3584 | 3807 | 0.9413 | 0.9528 |
Hs 578T | Afatinib | 0.12 | uM | LJP6 | 3 | G23 | 72 | hr | 658 | 3786 | 3769 | 1.0043 | 1.0034 |
Hs 578T | Afatinib | 0.37 | uM | LJP6 | 1 | G22 | 72 | hr | 658 | 3558 | 3705 | 0.9601 | 0.9676 |
Hs 578T | Afatinib | 0.37 | uM | LJP6 | 2 | G22 | 72 | hr | 658 | 3717 | 3807 | 0.9762 | 0.9811 |
Hs 578T | Afatinib | 0.37 | uM | LJP6 | 3 | G22 | 72 | hr | 658 | 3559 | 3769 | 0.9441 | 0.9548 |
Hs 578T | Afatinib | 1.11 | uM | LJP6 | 1 | G21 | 72 | hr | 658 | 3315 | 3705 | 0.8945 | 0.9126 |
Hs 578T | Afatinib | 1.11 | uM | LJP6 | 2 | G21 | 72 | hr | 658 | 3419 | 3807 | 0.8980 | 0.9168 |
Hs 578T | Afatinib | 1.11 | uM | LJP6 | 3 | G21 | 72 | hr | 658 | 3289 | 3769 | 0.8725 | 0.8945 |
Hs 578T | Afatinib | 3.33 | uM | LJP6 | 1 | G20 | 72 | hr | 658 | 3364 | 3705 | 0.9078 | 0.9239 |
Hs 578T | Afatinib | 3.33 | uM | LJP6 | 2 | G20 | 72 | hr | 658 | 3360 | 3807 | 0.8825 | 0.9036 |
Hs 578T | Afatinib | 3.33 | uM | LJP6 | 3 | G20 | 72 | hr | 658 | 3444 | 3769 | 0.9136 | 0.9295 |
Hs 578T | Afatinib | 10 | uM | LJP6 | 1 | G19 | 72 | hr | 658 | 461 | 3705 | 0.1244 | -0.1331 |
Hs 578T | Afatinib | 10 | uM | LJP6 | 2 | G19 | 72 | hr | 658 | 440 | 3807 | 0.1156 | -0.1470 |
Hs 578T | Afatinib | 10 | uM | LJP6 | 3 | G19 | 72 | hr | 658 | 470 | 3769 | 0.1247 | -0.1252 |
Hs 578T | GSK1904529A | 0.04 | uM | LJP6 | 1 | H24 | 72 | hr | 658 | 3424 | 3705 | 0.9239 | 0.9375 |
Hs 578T | GSK1904529A | 0.04 | uM | LJP6 | 2 | H24 | 72 | hr | 658 | 3390 | 3807 | 0.8903 | 0.9103 |